10 studies found for:    nAChR
Show Display Options
Rank Status Study
1 Recruiting Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Conditions: Schizophrenia;   Impaired Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
2 Recruiting Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects Receiving Chronic Stable Atypical Antipsychotic Therapy
Conditions: Schizophrenia;   Impaired Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
3 Not yet recruiting A 40-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Conditions: Schizophrenia;   Impaired Cognition
Intervention: Drug: EVP-6124
4 Completed Nicotinic Receptor Levels After Stopping Smoking
Condition: Nicotine Addiction
Intervention: Drug: 2-[18F]-fluro-3-[2(S)-2-azethidinylmethoxy]-pyridine
5 Recruiting Brain Nicotine Receptor Density in Veteran Smokers
Condition: Positron Emission Tomography
Intervention:
6 Suspended Study of Nicotine Patches in Patients With Sarcoidosis
Condition: Pulmonary Sarcoidosis
Intervention: Drug: nicotine patch
7 Completed Brain Imaging in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: [123] 5-I-A-85380
8 Recruiting Role of SLURP-1 in Melanoma and Melanoma Stem Cells
Condition: Melanoma;
Intervention:
9 Completed Anti-inflammatory Effects of GTS-21 After LPS
Conditions: Endotoxemia;   Sepsis;   Vagal Activity
Interventions: Drug: GTS-21, [3-(2,4-dimethoxybenzylidene)-anabaseine dihydrochloride];   Drug: Placebo;   Drug: Lipopolysaccharide E. Coli 113:H 10:K negative
10 Recruiting Nicotine Receptor Levels and Smoking Cessation
Conditions: Smoking Cessation;   Nicotine Addiction
Intervention: Drug: Nictonie Patch, Verenacline

Indicates status has not been verified in more than two years